VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
Clinical trial NCT00431704 · UNKNOWN
Trial details
- NCT number
- NCT00431704
- Sponsor
- National Cancer Institute, Naples
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2023-12-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.